Renwang Chen

415 total citations
21 papers, 279 citations indexed

About

Renwang Chen is a scholar working on Oncology, Computer Vision and Pattern Recognition and Molecular Biology. According to data from OpenAlex, Renwang Chen has authored 21 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 4 papers in Computer Vision and Pattern Recognition and 3 papers in Molecular Biology. Recurrent topics in Renwang Chen's work include Cancer survivorship and care (5 papers), Generative Adversarial Networks and Image Synthesis (4 papers) and Face recognition and analysis (4 papers). Renwang Chen is often cited by papers focused on Cancer survivorship and care (5 papers), Generative Adversarial Networks and Image Synthesis (4 papers) and Face recognition and analysis (4 papers). Renwang Chen collaborates with scholars based in China, United States and Switzerland. Renwang Chen's co-authors include Jue Wang, Ting Hu, Jing Cheng, Jianli Hu, Shengli Yang, Qiong Wang, Qiushuang Wang, Ting Hu, Jing Cheng and Qiong Wang and has published in prestigious journals such as Cancer Letters, BMC Cancer and Digestive Diseases and Sciences.

In The Last Decade

Renwang Chen

21 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renwang Chen China 11 102 62 61 58 54 21 279
Mircea-Sebastian Şerbănescu Romania 10 71 0.7× 59 1.0× 74 1.2× 25 0.4× 118 2.2× 90 422
Mirela Gherghe Romania 9 82 0.8× 27 0.4× 61 1.0× 36 0.6× 37 0.7× 38 257
Luca Cima Italy 10 59 0.6× 96 1.5× 28 0.5× 47 0.8× 50 0.9× 31 349
Fatma Tokat Türkiye 12 67 0.7× 59 1.0× 21 0.3× 23 0.4× 89 1.6× 45 378
Thomas M. Gudewicz United States 9 49 0.5× 115 1.9× 38 0.6× 37 0.6× 30 0.6× 14 343
Juan Antonio Retámero Spain 8 82 0.8× 25 0.4× 17 0.3× 22 0.4× 116 2.1× 13 299
Sari Suortamo United Kingdom 3 65 0.6× 24 0.4× 36 0.6× 19 0.3× 64 1.2× 4 255
Anh N. Le United States 9 95 0.9× 31 0.5× 29 0.5× 28 0.5× 19 0.4× 30 229
Ibrahim N. Muhsen United States 10 75 0.7× 52 0.8× 29 0.5× 12 0.2× 42 0.8× 41 292
Prasanna Kumar India 10 125 1.2× 36 0.6× 15 0.2× 44 0.8× 59 1.1× 28 320

Countries citing papers authored by Renwang Chen

Since Specialization
Citations

This map shows the geographic impact of Renwang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renwang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renwang Chen more than expected).

Fields of papers citing papers by Renwang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renwang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renwang Chen. The network helps show where Renwang Chen may publish in the future.

Co-authorship network of co-authors of Renwang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Renwang Chen. A scholar is included among the top collaborators of Renwang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renwang Chen. Renwang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Ting, et al.. (2023). Predicting acute radiation dermatitis in breast cancer: a prospective cohort study. BMC Cancer. 23(1). 537–537. 15 indexed citations
2.
Chen, Renwang, et al.. (2023). Learning Neural Proto-Face Field for Disentangled 3D Face Modeling in the Wild. 382–393. 3 indexed citations
3.
Chen, Renwang, et al.. (2022). Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory in Breast Cancer Patients. Current Medical Science. 42(2). 426–433. 6 indexed citations
4.
Wang, Qiong, Ting Hu, Renwang Chen, et al.. (2022). Effect of a Novel Soaking Solution Used in Patients With Hand-Foot Syndrome as a Result of Capecitabine Treatment: A Randomized and Self-Controlled Trial. Clinical Breast Cancer. 22(5). e685–e690. 2 indexed citations
5.
Peng, Xin, Renwang Chen, Yi Yang, et al.. (2022). High recurrence of lymphedema and influencing factors in discharged breast cancer patients during the COVID‐19 pandemic: A multicenter, cross‐sectional survey. Cancer Medicine. 11(19). 3572–3580. 4 indexed citations
6.
7.
Wang, Qiong, et al.. (2021). Risk Factors Related to Acute Radiation Dermatitis in Breast Cancer Patients After Radiotherapy: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 11. 738851–738851. 54 indexed citations
8.
Yang, Shengli, Yao Huang, Mengni Chen, et al.. (2021). The status of anxiety state among cancer patients and their relatives during coronavirus disease 2019 (COVID-19) in Hubei, China. Annals of Palliative Medicine. 10(4). 4601–4611. 7 indexed citations
9.
Yang, Shengli, Guiling Li, Tao� Zhang, et al.. (2021). Solid Tumor Complicated With Venous Thromboembolism: A 10-Year Retrospective Cross-Sectional Study. Clinical and Applied Thrombosis/Hemostasis. 27. 2874374012–2874374012. 11 indexed citations
10.
Zhang, Zhenyu, Renwang Chen, Ying Tai, et al.. (2021). Learning to Aggregate and Personalize 3D Face from In-the-Wild Photo Collection. 14209–14219. 21 indexed citations
11.
Wang, Jue, Yangyang Chen, Renwang Chen, Lu Wu, & Jing Cheng. (2020). Application of apatinib after multifaceted therapies for metastatic breast cancer. Translational Cancer Research. 9(8). 4488–4497. 7 indexed citations
12.
Wen, Lu, Shengli Yang, Pindong Li, et al.. (2020). iASPP-Mediated ROS Inhibition Drives 5-Fu Resistance Dependent on Nrf2 Antioxidative Signaling Pathway in Gastric Adenocarcinoma. Digestive Diseases and Sciences. 65(10). 2873–2883. 9 indexed citations
13.
Ren, Yanqiao, Lei Chen, Songjiang Huang, et al.. (2020). Transarterial chemoembolization of unresectable systemic chemotherapy refractory liver metastases: a retrospective single-center analysis. Abdominal Radiology. 45(9). 2862–2870. 10 indexed citations
14.
Wang, Qiushuang, Liangliang Shi, Fei Sun, et al.. (2019). High Expression of ANXA2 Pseudogene ANXA2P2 Promotes an Aggressive Phenotype in Hepatocellular Carcinoma. Disease Markers. 2019. 1–11. 25 indexed citations
15.
Chen, Renwang, et al.. (2019). Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory Gastrointestinal Cancer Module (MDASI-GI-C). Journal of Pain and Symptom Management. 57(4). 820–827. 25 indexed citations
16.
Chen, Renwang & Bingbing Ni. (2019). Face Swapping with Limited Input. 40–43. 1 indexed citations
17.
Chen, Mengni, Shengli Yang, Fan Li, et al.. (2019). Combined Antiangiogenic Therapy and Immunotherapy Is Effective for Pancreatic Cancer With Mismatch Repair Proficiency but High Tumor Mutation Burden. Pancreas. 48(9). 1232–1236. 14 indexed citations
18.
Chen, Chen, Xiefan Fang, George Chen, et al.. (2018). Peritumoral overexpression of ZBP‑89 is associated with unfavorable disease‑free survival rates in patients with hepatocellular carcinoma following hepatectomy. Oncology Letters. 15(5). 7828–7836. 1 indexed citations
19.
Chen, Renwang, Meng-jun Qiu, Yaobing Chen, et al.. (2018). Analysis of the clinicopathological features and prognostic factors of primary hepatic neuroendocrine tumors. Oncology Letters. 15(6). 8604–8610. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026